BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11118857)

  • 41. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.
    Gerna G; Zipeto D; Parea M; Revello MG; Silini E; Percivalle E; Zavattoni M; Grossi P; Milanesi G
    J Infect Dis; 1991 Sep; 164(3):488-98. PubMed ID: 1651361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification.
    Zhang F; Tetali S; Wang XP; Kaplan MH; Cromme FV; Ginocchio CC
    J Clin Microbiol; 2000 May; 38(5):1920-5. PubMed ID: 10790122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring human cytomegalovirus infection in transplant recipients.
    Baldanti F; Lilleri D; Gerna G
    J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation: a prospective study.
    Rayes N; Seehofer D; Lullius SG; Stein A; May G; Kahl A; Frei U; Neuhaus P; Meisel H
    Ann Transplant; 2005; 10(2):23-8. PubMed ID: 16218029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Ishii K; Onishi Y; Miyamura N; Fukuhara N; Ishizawa K; Nakanishi M; Ohnaka S; Miyasaka T; Kanno E; Kawakami K; Harigae H; Kaku M
    J Med Virol; 2017 Jul; 89(7):1265-1273. PubMed ID: 28165158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human cytomegalovirus-associated periodontitis in renal transplant patients.
    Nowzari H; Jorgensen MG; Aswad S; Khan N; Osorio E; Safarian A; Shidban H; Munroe S
    Transplant Proc; 2003 Dec; 35(8):2949-52. PubMed ID: 14697947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients.
    Lam KM; Oldenburg N; Khan MA; Gaylore V; Mikhail GW; Strouhal PD; Middeldorp JM; Banner N; Yacoub M
    J Heart Lung Transplant; 1998 Jun; 17(6):555-65. PubMed ID: 9662090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis of human cytomegalovirus infections in the immunocompromised host.
    Gerna G; Zavattoni M; Percivalle E; Zella D; Torsellini M; Revello MG
    Clin Diagn Virol; 1996 May; 5(2-3):181-6. PubMed ID: 15566876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
    Hebart H; Müller C; Löffler J; Jahn G; Einsele H
    Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients.
    Pellegrin I; Garrigue I; Ekouevi D; Couzi L; Merville P; Merel P; Chene G; Schrive MH; Trimoulet P; Lafon ME; Fleury H
    J Infect Dis; 2000 Jul; 182(1):36-42. PubMed ID: 10882579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection.
    Benmarzouk-Hidalgo OJ; Cordero E; Martín-Peña A; García-Prado E; Gentil MA; Gomez-Bravo MA; Barrera-Pulido L; Cisneros JM; Perez-Romero P
    Antivir Ther; 2009; 14(5):641-7. PubMed ID: 19704166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a quantitative-competitive PCR for quantification of human cytomegalovirus load and comparison with antigenaemia, viraemia and pp67 RNA detection by nucleic acid sequence-based amplification.
    Bergallo M; Costa C; Tarallo S; Daniele R; Merlino C; Segoloni GP; Negro Ponzi A; Cavallo R
    Panminerva Med; 2006 Jun; 48(2):119-27. PubMed ID: 16953149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients.
    Niubò J; Pérez JL; Martínez-Lacasa JT; García A; Roca J; Fabregat J; Gil-Vernet S; Martín R
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):19-24. PubMed ID: 8988759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients.
    Sahin DG; Gunduz E; Kasifoglu N; Akay OM; Us T; Gulbas Z
    Adv Ther; 2013 Aug; 30(8):784-91. PubMed ID: 23959787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
    Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
    J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.